Statin Selection in Special Patient Populations: A Case Challenge

Goals

Multiple Challenges in Statin Selection

Case 1: Lipid Clinic Referral James Smith, 51 Years Old

Case 1: Lipid Clinic Referral (cont)

Understanding the Changing CV Risk Burden in HIV infection

Reasons for Increased ASCVD Risk in HIV Infection

Assessment of CV Risk in Primary Prevention for an HIV-Infected Patient

Match Lipid Treatment to Level of Risk Per NLA, Count Risk Factors, Add HIV as Additional Factor

Use of Statins With PIs

INTREPID Safety-Efficacy Trial

REPRIEVE CV Outcomes Trial

Statin-Associated Myopathy: Risk Factors and Cytochrome P450 Associations

Case 2: Statin Intolerance Sue Jones; 63 Year Old

What Are SAMS?

Spectrum of SAMS: NLA Statin Safety Task Force

SAMS Impact on Statin Therapy

Nocebo Effect

NLA Statin Myalgia Clinical Index Score

How to Manage Statin Intolerance and Recognize Risk Factors

Thoughtful Statin Selection

Abbreviations

Abbreviations (cont)